ArticleDiabetic medicine : a journal of the British Diabetic Association2025
Diabetes distress screening using PAID-5 and PAID-1 among adults attending a tertiary multidisciplinary type 1 diabetes clinic.
Article in Diabetic medicine : a journal of the British Diabetic Association, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed.
- Type 1 diabetes-specific distress among adults with type 1 diabetes in Japan.Journal of diabetes investigation · 2026Article
- Diabetes distress screening using PAID-5 and PAID-1 among adults attending a tertiary multidisciplinary type 1 diabetes clinic.Diabetic medicine : a journal of the British Diabetic Association · 2025Article
- Beyond glycemic control: a holistic perspective on psychosocial support in outpatient diabetes management.Frontiers in endocrinology · 2025Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
11 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
aimsLiving with type 1 diabetes can be challenging, and diabetes distress may be overlooked during time-constrained clinical assessments. Screening for diabetes distress with the one-item Problem Areas in Diabetes Scale (PAID)-1, in conjunction with the five-item PAID-5, may offer an efficient method to improve type 1 diabetes assessment. We aimed to evaluate the utility of this approach to identify possible diabetes distress and its clinically significant covariates.
methodsWe performed a retrospective, real-world, cross-sectional study of adults attending a multidisciplinary type 1 diabetes outpatient clinic at a tertiary centre from October 2023 to September 2024, inclusive. Screening was conducted using PAID-5 (incorporating PAID-1) during the initial consultation.
resultsThere were 160 adults included (median age 38 years [IQR 30-52]; type 1 diabetes duration 16 years [4-24]; n = 138 [86%] were using continuous glucose monitoring [CGM]). PAID-5 median score was 8 [4-12]; 83 individuals (52%) had a score ≥8, indicating possible diabetes distress. Higher diabetes distress screening scores were associated with CGM metrics indicative of hyperglycaemia; no associations were observed with CGM-detected hypoglycaemia. PAID-1 had sensitivity 81% and specificity 96% for PAID-5-detected diabetes distress.
conclusionsA high prevalence of diabetes distress was detected on screening among adults attending a tertiary type 1 diabetes service. This highlights the importance of psychological assessment and implementation of management strategies for diabetes distress to reduce the burden of living with type 1 diabetes. Our findings support the use of the PAID-1 as a rapid screening tool to assess for diabetes distress.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.